Top Markets
Coin of the day
D. Western Therapeutics Institute, Inc. D. Western Therapeutics Institute, Inc.

D. Western Therapeutics Institute, Inc.

4576
株式のランク #27584
D. Western Therapeutics Institute, Inc. is a biotechnology enterprise focused... D. Western Therapeutics Institute, Inc. is a biotechnology enterprise focused on the research, discovery, and innovation of various pharmaceutical drugs. The company's current portfolio includes GLANATEC and GLA-ALPHA, ophthalmic solutions prescribed for glaucoma and ocular hypertension, as well as DW-1001, another medication for eye conditions. It also provides DWR-2206, a regenerative cell-based product targeting bullous keratopathy, and DW-1002, an ophthalmic surgical aid used for staining membranes like ILM, ALC, ERM, and PVR during cataract operations. In its development pipeline, the company is advancing DW-5LBT, a lidocaine patch designed to alleviate neuropathic pain post-shingles. Additionally, K-321 is progressing through Phase III clinical trials for Fuch endothelial corneal dystrophy, and H-1337, a multi-kinase inhibitor, has commenced Phase IIb trials for glaucoma and ocular hypertension treatment. The firm was established in 1999 and operates from its headquarters in Nagoya, Japan.
株価
$0.56109583
時価総額
$32.25M
変化(1日)
2.38%
変化(1年)
-24.84%
JP
取引 D. Western Therapeutics Institute, Inc. (4576)

カテゴリー

D. Western Therapeutics Institute, Inc.(4576)の株価履歴
終値の最高値: $0.54 (2026-08-01)

終値の最安値: $4.52 (2009-10-01)
D. Western Therapeutics Institute, Inc. の株価履歴(2009 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) -3.20%
2025 -30.56%
2024 -9.73%
2023 -46.54%
2022 -2.92%
2021 -31.60%
2020 -43.81%
2019 25.57%
2018 -7.47%
2017 26.04%
2016 -29.93%
2015 -48.90%
2014 10.29%
2013 445.99%
2012 1.08%
2011 -7.93%
2010 -31.27%
2009 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$121.38 -14.54%
AU
$753.28 5.84%
CH